Evolent Health (EVH) reported earnings on Thur 2 Nov 2017 (a/h)

• Headquarters: Virginia
• Founded: 2011
• evolenthealth.com

** charts before earnings **

 

** charts after earnings **

Evolent Health misses by $0.10, beats on revs; guides FY17 revs above consensus 

• Reports Q3 (Sep) loss of $0.18 per share, excluding non-recurring items, $0.10 worse than the Capital IQ Consensus of ($0.08); revenues rose 79.2% year/year to $107.9 mln vs the $104.49 mln Capital IQ Consensus.
• Co issues upside guidance for FY17, sees FY17 revs of $432-434 mln, excluding non-recurring items, vs. $427.39 mln Capital IQ Consensus Estimate.
• For the three months ended December 31, 2017, Adjusted Revenue is expected to be in the range of $110.0 million to $112.0 million and Adjusted EBITDA is expected to be in the range of $3.0 million to $4.0 million. For the full year 2017, we expect Adjusted Revenue to be in the range of $432.0 million to $434.0 million and Adjusted EBITDA to be in the range of $(3.0) million to $(2.0) million.
• Lives on platform of approximately 2.7 million, an increase of 84.7% 

Evolent Health (EVH) began trading on the NYSE on 5 June 2015

• Evolent Health (NYSE:EVH) raised $195 million at 17, above the high end of its estimated range of 14 to 16, offering 11.5 million shares. 
• The company provides a software platform designed to help hospitals and health care companies improve the way patient care is delivered.

Evolent’s HQ at the intersection of Wilson Blvd. and Glebe Rd. in the Ballston neighborhood of Arlington, Virginia.

Evolent Health, Inc. is engaged in the healthcare delivery and payment markets. The Company's platform enables providers to migrate their economic orientation from fee-for-service (FFS) reimbursement to value-based payment models. It provides an end-to-end, technology-enabled services platform for providers to transition their organization in value-based payment models. It markets and sells services to providers throughout the United States. The Company works with its partners in two phases. In the transformation phase, it works with its partners to develop a plan for their transition to a value-based care model. During the second portion of the transformation phase, the Company works with its partner to implement the Blueprint. During the transformation phase, the Company seeks to enter into long-term agreements with its partners. In the platform and operations phase, the Company establishes a local market presence and embeds its resources alongside the Company's partners.

Address

800 N Glebe Rd Ste 500
ARLINGTON, VA 22203-2151
United States